← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2007Last known activity
Jan 10, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 6 trials)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (11)
- NCT07292207CollaboratorPhase 2Jan 10, 2026
- NCT06976944Sponsor investigatorPhase 2Jul 31, 2025
- NCT06976944Lead sponsorPhase 2Jul 31, 2025
- NCT06853496Lead sponsorPhase 1Mar 13, 2025
- NCT06853496Sponsor investigatorPhase 1Mar 13, 2025
- NCT07190443Lead sponsorPhase 3Feb 7, 2025
- NCT07190443Sponsor investigatorPhase 3Feb 7, 2025
- NCT04732598Lead sponsorPhase 3Jan 21, 2021
- NCT04732598Reponsible party - principal investigatorPhase 3Jan 21, 2021
- NCT00561275Lead sponsorPhase 1Oct 1, 2007
- NCT00561275Overall official - principal investigatorPhase 1Oct 1, 2007
Details
- Last known activity
- Jan 10, 2026